Cargando…
Is there a role for immune checkpoint blockade in metastatic uveal melanoma?
Autores principales: | Schilling, Bastian, Schneider, Tim, Möller, Inga, Sucker, Antje, Paschen, Annette, Schadendorf, Dirk, Griewank, Klaus G |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4315232/ http://dx.doi.org/10.1186/1479-5876-13-S1-K20 |
Ejemplares similares
-
On translating technology research into industrial applications
por: Wong, Stephen T C
Publicado: (2014) -
TVET as an important factor in country’s economic development
por: Pavlova, Margarita
Publicado: (2014) -
Assisted technology for daily living
por: Tong, Kai-yu Raymond
Publicado: (2014) -
Combining targeted and immunotherapy: BRAF inhibitor dabrafenib (D) ± the MEK inhibitor trametinib (T) in combination with ipilimumab (Ipi) for V600E/K mutation-positive unresectable or metastatic melanoma (MM)
por: Puzanov, Igor
Publicado: (2015) -
The immune-related role of BRAF in melanoma
por: Tomei, Sara, et al.
Publicado: (2015)